PATENT CLAIM ANALYSIS

Application Number: 15768133
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "043000"]

Abstract:
The invention is directed to combinations of acamprosate and ribavirin, to pharmaceutical compositions, kits and treatment methods for the treatment or prevention of neurological damage.

Claim (Index 9):
The combination or pharmaceutical composition for use according to  claim 8 , wherein the neurological damage is a condition or disease selected from the group consisting of peripheral nerve lesion, lesions of efferent/afferent fibers, lesions of the posterior root of the spinal cord, lesions or traumatic cranial neuropathy affecting cranial nerves, diseases of the motoneurons of the posterior root of the spinal cord or motor axons, diseases affecting lower motoneurons, acute and chronic inflammatory pain, neuropathic pain, neuritis, phantom limb pain, radiculopathy, traumatic nerve injury, inflammatory and neurodegenerative processes ensuing after the implantation of surgical prostheses.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 91.0
- Lexical Diversity: 1.21739
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14861169', '13691981', '13706907', '14473245', '14479614']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7735193789815112
- 35 USC 102 Novelty (BERT): 0.5238452929026411
- Combined Prediction Score: 0.7485519703736243
- Mean Citation Score: 278.174786
- Max Citation Score: 286.4421
- Similarity Product: 175.27638858427403

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test